These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 791332
1. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine. Johnson BF, LaBrooy J, Munro-Faure AD. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332 [Abstract] [Full Text] [Related]
2. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158). Johnson BF, LaBrooy J, Munro-Faure AD. Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558 [Abstract] [Full Text] [Related]
7. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension. West MJ, Wing LM, Mulligan J, Walkley J, Grygiel JJ, Graham JR, Chalmers JP. Med J Aust; 1980 Mar 08; 1(5):224-5. PubMed ID: 6990215 [Abstract] [Full Text] [Related]
10. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. Hansson L, Hänel B. Int J Clin Pharmacol Biopharm; 1976 Oct 08; 14(3):195-8. PubMed ID: 12115 [Abstract] [Full Text] [Related]
12. Treatment of hypertension with labetalol. Bolli P, Waal-Manning HJ, Simpson FO, Seeman HM. N Z Med J; 1977 Dec 28; 86(602):557-63. PubMed ID: 306082 [Abstract] [Full Text] [Related]
13. Labetalol and pindolol in the treatment of hypertension: a comparative study. Romo M, Halttunen P, Saarinen P, Sarna S. Ann Clin Res; 1979 Dec 28; 11(6):249-52. PubMed ID: 398184 [Abstract] [Full Text] [Related]
14. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)]. Martinand A, Lardoux H, Corvol P, Milliez P. Nouv Presse Med; 1980 Sep 27; 9(35):2565-8. PubMed ID: 7001349 [Abstract] [Full Text] [Related]
15. Labetalol in resistant hypertension. Dargie HJ, Dollery CT, Daniel J. Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):751-5. PubMed ID: 990154 [Abstract] [Full Text] [Related]
16. Labetalol in severe and resistant hypertension. Williams LC, Murphy MJ, Parsons V. Br J Clin Pharmacol; 1979 Aug 27; 8(Suppl 2):143S-147S. PubMed ID: 526395 [Abstract] [Full Text] [Related]
17. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa. Al-Damluji SF, Al-Khalidi A, Shaarbaf H, Tawfiq NH. Pharmatherapeutica; 1982 Aug 27; 3(2):133-9. PubMed ID: 7048338 [Abstract] [Full Text] [Related]
18. [Treatment of arterial hypertension with labetalol. A polycentric study]. G Ital Cardiol; 1982 Aug 27; 12(10):729-35. PubMed ID: 7182212 [Abstract] [Full Text] [Related]
19. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension. Chalmers AG, Hunter J, Lees CD, Millar JA, Brown JJ, Robertson JI. Br J Clin Pharmacol; 1979 Aug 27; 8(Suppl 2):183S-187S. PubMed ID: 526399 [Abstract] [Full Text] [Related]
20. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension. Ronne-Rasmussen JO, Andersen GS, Jensen NB, Andersson E. Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):805-8. PubMed ID: 990157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]